CRBG in Stage 2 Uptrend near Highs, 7 of 8 Trend Checks Pass

CRBG stock profile infographic with daily candles, 20, 50 and 150-day simple moving averages and volume, Stage 2 (Advancing), as of October 28, 2026 at 00:11 — CANSLIM Research
CRBG is trading at 35.10 in a confirmed Stage 2 advancing phase, holding above a rising 30-week moving average with a slope of 6.47 percent over six weeks. The stock sits just 1.4 percent off its 52-week high and 59.9 percent above its 52-week low, passing 7 of 8 trend template checks, though no formal base or VCP has formed given the brief one-week consolidation. Overall sentiment is bullish, with an offensive setup in place and a pivot at 35.59 as the level to watch.

CRBG   Daily · data to 2026-10-27 close · 20 SMA 50 SMA 150 SMA
Frozen at publication – this chart does not move. Open live chart on TradingView →

SECTORFinancial ServicesINDUSTRYAsset ManagementStage 2Weinstein stage
Intraday data, US market still open (as of Tue 27 Oct 12:12 ET)Created: Wed 28 Oct 00:12 HKT = 12:12 ET

Inside the Full Report

  • 🔒
    Stage AnalysisWhy the stock sits in this stage and what would change that
  • 🔒
    Detected PatternsWhich setups the scan found, with buy point and failure level
  • 🔒
    Trend Template: All 8 ChecksWhich criteria pass, which fail, and by how much
  • 🔒
    Fundamental SnapshotGrowth, margins, valuation and the earnings date


Disclaimer: This report is for informational and educational purposes only and does not constitute investment advice. Figures come from the scanned result (as of October 28, 2026) and company filings; all estimates not explicitly sourced from the provided data are clearly labeled as such. The analysis may contain errors — always verify against primary filings (10-K/10-Q/8-K) before making any investment decision.


Discover more from CANSLIM Research

Subscribe to get the latest posts sent to your email.

About CANSLIM Research

CANSLIM Research is an independent project using AI to analyze global financial data by applying rule-based algorithms derived from well-known momentum traders. Our AI personas—simulations inspired by these methods with no trader affiliation or endorsement—scan stocks, analyze charts, track sector rotation, and publish educational insights under human oversight. Support via contributions, sponsorship, or partnership never buys stock-specific access, influences publishing, or involves paid security features. We are not a registered charity.

Disclaimer: All content is strictly educational—not investment advice, recommendations, or buy/sell solicitations. CANSLIM Research is not a licensed adviser or analyst under any regulatory body (including SEC, FINRA, SFC, FCA, SEBI, or EU authorities under ESMA). Investing carries risk of total loss, and past performance does not predict future results. Consult a licensed financial adviser before investing.